Persistent emotional stress, fatigue and impaired neurocognitive function in recovered COVID-19 patients: a longitudinal prospective study. (1st June 2022)
- Record Type:
- Journal Article
- Title:
- Persistent emotional stress, fatigue and impaired neurocognitive function in recovered COVID-19 patients: a longitudinal prospective study. (1st June 2022)
- Main Title:
- Persistent emotional stress, fatigue and impaired neurocognitive function in recovered COVID-19 patients: a longitudinal prospective study
- Authors:
- Rogiers, A.
Launay, S.
Duque, G.
Soukias, E.
Van Eycken, S.
Besse-Hammer, T.
Sanchez-Rodriguez, D.
Chalon, M.
Gazagne, M.-D.
Maillart, E.
Benoit, F.
Surquin, M.
Corrazza, F.
Michel, O.
Kornreich, C. - Abstract:
- Abstract : Introduction: Several surveys report that post-COVID-19 patients (pts) could be at risk of persistent emotional distress, fatigue and impaired neurocognitive function (NCF). Objectives: The aim was to assess emotional distress, fatigue and NCF in order to provide adequate care. Methods: Patients with persistent physical or mental symptoms, at least 8 weeks post-COVID-19, were eligible for this ongoing prospective longitudinal single center trial. Data on depression, anxiety, cognition, post-traumatic stress symptoms (PTSS) and fatigue were collected using 4 validated questionnaires at study entry (T0) and at 6 months (T1). Results: Ninety-three pts were recruited between November 2020-March 2021. Test results from 64 eligible pts (15 male pts) were analyzed at T0; 63 pts (98%) were treated in outpatient settings. Median age was 47 years [range 27-75]). Median time since COVID-19 was 29 weeks [range 8-53]. Twenty-two pts (34%) had a history of psychiatric disorders. According to the Hospital Anxiety Depression Scale (HADS), 44 pts (73%) reported anxiety symptoms and 26 pts (41%) reported depressive symptoms; 48 pts (69%) reported cognitive complaints according to the Cognitive Failure Questionnaire and 29 pts (45%) suffered from PTSS, according to the Post-Traumatic Stress Disorder Checklist-Civilian Version (PCL-C). Fifty-five pts (86%) had an elevated score on the Fatigue Severity Scale, indicating severe fatigue. Twenty-seven pts (42%) were still on sick leaf.Abstract : Introduction: Several surveys report that post-COVID-19 patients (pts) could be at risk of persistent emotional distress, fatigue and impaired neurocognitive function (NCF). Objectives: The aim was to assess emotional distress, fatigue and NCF in order to provide adequate care. Methods: Patients with persistent physical or mental symptoms, at least 8 weeks post-COVID-19, were eligible for this ongoing prospective longitudinal single center trial. Data on depression, anxiety, cognition, post-traumatic stress symptoms (PTSS) and fatigue were collected using 4 validated questionnaires at study entry (T0) and at 6 months (T1). Results: Ninety-three pts were recruited between November 2020-March 2021. Test results from 64 eligible pts (15 male pts) were analyzed at T0; 63 pts (98%) were treated in outpatient settings. Median age was 47 years [range 27-75]). Median time since COVID-19 was 29 weeks [range 8-53]. Twenty-two pts (34%) had a history of psychiatric disorders. According to the Hospital Anxiety Depression Scale (HADS), 44 pts (73%) reported anxiety symptoms and 26 pts (41%) reported depressive symptoms; 48 pts (69%) reported cognitive complaints according to the Cognitive Failure Questionnaire and 29 pts (45%) suffered from PTSS, according to the Post-Traumatic Stress Disorder Checklist-Civilian Version (PCL-C). Fifty-five pts (86%) had an elevated score on the Fatigue Severity Scale, indicating severe fatigue. Twenty-seven pts (42%) were still on sick leaf. Diminished social support and psychiatric history were predictive factors for neurocognitive dysfunction and PTSS. Conclusions: A majority of patients who recovered physically from COVID-19, are at risk for suffering from persistent anxiety, PTSS and neurocognitive dysfunction. Disclosure: No significant relationships. … (more)
- Is Part Of:
- European psychiatry. Volume 65:Supplement 1(2022)
- Journal:
- European psychiatry
- Issue:
- Volume 65:Supplement 1(2022)
- Issue Display:
- Volume 65, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 65
- Issue:
- 1
- Issue Sort Value:
- 2022-0065-0001-0000
- Page Start:
- S496
- Page End:
- S496
- Publication Date:
- 2022-06-01
- Subjects:
- Covid-19 -- cognitive function -- post-traumatic stress symptoms -- Anxiety
Psychiatry -- Periodicals
Mental illness -- Periodicals
Electronic journals
616.89 - Journal URLs:
- https://www.cambridge.org/core/journals/european-psychiatry ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09249338 ↗
http://www.sciencedirect.com/science/journal/09249338 ↗
http://www.elsevier.com/homepage/elecserv.htt ↗ - DOI:
- 10.1192/j.eurpsy.2022.1261 ↗
- Languages:
- English
- ISSNs:
- 0924-9338
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.842700
British Library HMNTS - ELD Digital store - Ingest File:
- 23307.xml